Propionic Acid

Propionic Acid

SCHEMBL4153202

CCC(=O)O.COc1ccc2c(c1)[nH]c(=O)c1[nH]ccc12

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.47
BCHE P06276 2/20 0.47
DYRK1A Q13627 5/20 0.46
GPR17 Q13304 1/20 0.46
CDK4 P11802 2/20 0.45
CCND1 P24385 2/20 0.45
CDK2 P24941 2/20 0.45
CCNE2 O96020 1/20 0.45
PRKACA P17612 1/20 0.45
PRKACG P22612 1/20 0.45
PRKACB P22694 1/20 0.45
CCNE1 P24864 1/20 0.45
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
KDM4E B2RXH2 7/20 0.44
GAA P10253 3/20 0.43
GSK3B P49841 2/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 4/20 0.42
HPGD P15428 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4167721 0.85 PRKAG1 (0.46) DYRK1AKDM4EGAAGSK3BALDH1A1
Propionic Acid SCHEMBL4162597 0.84 KDM4E (0.43) KDM4EGAAKMT2AALDH1A1HPGD
Propionic Acid SCHEMBL4159540 0.82 PARP1 (0.43) DYRK1ACDK2PRKACAKDM4EGSK3B
Propionic Acid SCHEMBL4166119 0.82 PARP1 (0.49) GPR17KDM4EKMT2AALDH1A1HPGD
Propionic Acid SCHEMBL4163220 0.80 KDM4E (0.37) KDM4EGAAKMT2AALDH1A1HPGD
Propionic Acid SCHEMBL4171576 0.79 PIM1 (0.46) KDM4EGAAKMT2AALDH1A1HPGD
SCHEMBL20138908 0.79 DYRK1A (0.54) ACHEBCHEDYRK1ACDK4CCND1
Propionic Acid SCHEMBL4164250 0.77 BRD4 (0.62) KDM4EGAAGSK3BKMT2AALDH1A1
Propionic Acid SCHEMBL4163726 0.77 BRD4 (0.54) KDM4EGAAGSK3BKMT2AALDH1A1
Propionic Acid SCHEMBL4176382 0.76 GRIN1 (0.35) DYRK1AKDM4EKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 ACHE 2453/4885BCHE 2994/4885DYRK1A 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.